Parmax Pharma Issues Corrigendum to EGM Notice

Parmax Pharma Ltd has issued a corrigendum to its Extraordinary General Meeting (EGM) notice dated June 8, 2026. The corrigendum addresses two key points: a correction in the proposed status/category of Ms. Sheetal Hiren Doshi in the warrant allottees table from 'Promoter*' to 'Promoter Group*', and a rectification of the hyperlink for the Practicing Company Secretary's Certificate. The EGM is scheduled for July 2, 2026, to be held via Video Conferencing. This corrigendum, along with the original EGM notice and explanatory statement, will be available on the company's website.